<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Psychopharmacology (Berl)</journal-id><journal-id journal-id-type="iso-abbrev">Psychopharmacology (Berl)</journal-id><journal-title-group><journal-title>Psychopharmacology</journal-title></journal-title-group><issn pub-type="ppub">0033-3158</issn><issn pub-type="epub">1432-2072</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39365438</article-id><article-id pub-id-type="pmc">PMC11861123</article-id>
<article-id pub-id-type="publisher-id">6695</article-id><article-id pub-id-type="doi">10.1007/s00213-024-06695-6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Investigation</subject></subj-group></article-categories><title-group><article-title>Oxytocin differentially modulates reward system responses to social and non-social incentives</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3129-8511</contrib-id><name><surname>Thurston</surname><given-names>Matthew D.</given-names></name><address><email>m.thurston@uq.edu.au</email><email>thurstonmattca@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Ericksen</surname><given-names>Lauren C.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Jacobson</surname><given-names>Maci M.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Bustamante</surname><given-names>Allison</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Koppelmans</surname><given-names>Vincent</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Mickey</surname><given-names>Brian J.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Love</surname><given-names>Tiffany M.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00rqy9422</institution-id><institution-id institution-id-type="GRID">grid.1003.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 9320 7537</institution-id><institution>Centre for Advanced Imaging, </institution><institution>The University of Queensland, </institution></institution-wrap>Brisbane, QLD 4067 Australia </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00rqy9422</institution-id><institution-id institution-id-type="GRID">grid.1003.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 9320 7537</institution-id><institution>Australian Institute for Bioengineering and Nanotechnology, </institution><institution>The University of Queensland, </institution></institution-wrap>Brisbane, QLD 4067 Australia </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03r0ha626</institution-id><institution-id institution-id-type="GRID">grid.223827.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2193 0096</institution-id><institution>Department of Psychiatry and Huntsman Mental Health Institute, </institution><institution>The University of Utah, </institution></institution-wrap>Salt Lake City, UT 84112 USA </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03r0ha626</institution-id><institution-id institution-id-type="GRID">grid.223827.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2193 0096</institution-id><institution>Department of Biomedical Engineering, </institution><institution>The University of Utah, </institution></institution-wrap>Salt Lake City, UT 84112 USA </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03r0ha626</institution-id><institution-id institution-id-type="GRID">grid.223827.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2193 0096</institution-id><institution>Department of Anesthesiology, </institution><institution>The University of Utah, </institution></institution-wrap>Salt Lake City, UT 84112 USA </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03r0ha626</institution-id><institution-id institution-id-type="GRID">grid.223827.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2193 0096</institution-id><institution>Interdepartmental Program in Neuroscience, </institution><institution>The University of Utah, </institution></institution-wrap>Salt Lake City, UT 84112 USA </aff></contrib-group><pub-date pub-type="epub"><day>4</day><month>10</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>4</day><month>10</month><year>2024</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>242</volume><issue>3</issue><fpage>449</fpage><lpage>460</lpage><history><date date-type="received"><day>3</day><month>4</month><year>2024</year></date><date date-type="accepted"><day>27</day><month>9</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Rationale</title><p id="Par1">Oxytocin has been shown to modulate behavior related to processing of monetary incentives and to regulate social and reproductive behavior, yet little is known about how oxytocin differentially influences neural responses to social and non-social incentives.</p></sec><sec><title>Objectives</title><p id="Par2">We aimed to evaluate the effects of oxytocin administration on behavioral and neural responses to social and monetary incentives.</p></sec><sec><title>Methods</title><p id="Par3">Twenty-eight healthy adults (age 18&#x02013;45 years) performed both monetary and social incentive tasks during blood oxygenation level dependent (BOLD) imaging. Intranasal oxytocin or placebo was administered before each scan using a double blind, randomized, cross-over design. Task performance and self-reported motivation and mood states were collected. Time-series analysis was conducted to assess the influence of oxytocin on the hemodynamic response in the ventral tegmental area and substantia nigra (VTA/SN) and nucleus accumbens (NAc).</p></sec><sec><title>Results</title><p id="Par4">Oxytocin demonstrated a multifaceted effect on VTA/SN and NAc when processing reward incentives, with it increasing BOLD response in VTA/SN and decreasing BOLD response in NAc during social incentive anticipation. A reversal of this was shown with decreased BOLD responses in the VTA/SN and increased BOLD response in the NAc during monetary incentive anticipation.</p></sec><sec><title>Conclusions</title><p id="Par5">Our findings suggest a more nuanced purpose of oxytocin when evaluating reward incentive decision making. It is possible that while oxytocin does increase salience to rewards, that it is more important for cognitive control when determining short-term versus long-term benefits in rewards. Future studies should more closely examine the relationship between oxytocin and delay discounting.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1007/s00213-024-06695-6.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Oxytocin</kwd><kwd>Reward incentives</kwd><kwd>BOLD time-series</kwd><kwd>fMRI</kwd><kwd>Social cognition</kwd><kwd>Psychopharmacology</kwd></kwd-group><funding-group><award-group><funding-source><institution>The University of Queensland</institution></funding-source></award-group><open-access><p> Open Access funding enabled and organized by CAUL and its Member Institutions</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag GmbH Germany, part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Oxytocin differentially modulates reward system responses to social and non-social incentives</title><p id="Par6">Cognitive incentive processes help motivate an individual to pursue fulfillment again in the future and help to teach them efficient ways to attain their goals (Verharen et al. <xref ref-type="bibr" rid="CR18">2020</xref>). Dysfunctions in this system can lead to clinical issues related to addiction, depression, and other disorders (Poulton and Hester <xref ref-type="bibr" rid="CR15">2020</xref>). This system can be delineated neuroanatomically by the mesolimbic pathway, which encompasses reciprocal projections from the ventral tegmental area (VTA) and substantia nigra (SN) to the nucleus accumbens (NAc) (Mickey et al. <xref ref-type="bibr" rid="CR12">2016</xref>; Der-Avakian et al. <xref ref-type="bibr" rid="CR4">2016</xref>). Interactions of dopaminergic and oxytocin systems with the mesolimbic pathway have been associated with the cognitive processing of incentives (Bromberg-Martin et al. <xref ref-type="bibr" rid="CR2">2010</xref>; Mickey et al. <xref ref-type="bibr" rid="CR12">2016</xref>; Love <xref ref-type="bibr" rid="CR10">2014</xref>).</p><p id="Par7">A recent meta-analysis attempted to determine whether the neuro circuitry of social versus non-social incentives were similar or different, by combining data from multiple studies that either used the monetary incentive delay task, used to measure non-social incentive activity, or a social incentive variant of the task known as the social incentive delay task (Gu et al. <xref ref-type="bibr" rid="CR6">2019</xref>). The study looked at activity specific to the anticipation period of these tasks across several regions related to reward. Overall, the study found almost identical activity during monetary and social incentive activity during win anticipation, supporting the hypothesis that social and monetary incentives are not processed differently. Another study also looked at the effects of oxytocin on monetary incentives in the VTA, substantia nigra, and NAc, and found that these regions were significantly modulated by oxytocin and that oxytocin effects were correlated with increased positive affect (Mickey et al. <xref ref-type="bibr" rid="CR12">2016</xref>).</p><p id="Par8">Several other studies have examined the influences of oxytocin on social and non-social incentive processes. Hu et al. (<xref ref-type="bibr" rid="CR7">2015</xref>) found that oxytocin particularly increased sensitivity to the anticipation of social feedback, and that this could possibly be due to increasing social salience in emotional and reward processing regions of the brain. Nawijn et al. (<xref ref-type="bibr" rid="CR14">2016</xref>) showed that intranasal oxytocin could potentially reduce anhedonia related symptoms of reward processing in patients with PTSD, suggesting that intranasal oxytocin could also be useful for augmenting clinical psychotherapy sessions. Spetter et al. (<xref ref-type="bibr" rid="CR17">2018</xref>) showed, in the case of food reward processing, oxytocin may simultaneously increase the reward response to food while also regulating the brain to select lower calorie foods, showing a possible multifaceted effect of oxytocin on reward processing. It should be noted that this multifaceted oxytocin effect was not replicated in monetary incentive reward processing. A study has shown that oxytocin may influence decision making accuracy (Zhou et al. <xref ref-type="bibr" rid="CR21">2024</xref>), while another study suggests that oxytocin does not influence reward network processing in males with or without autism spectrum disorder (Mayer et al. <xref ref-type="bibr" rid="CR11">2021</xref>).</p><p id="Par9">Anticipatory neural models of reward incentives have shown that incentives are either approached or avoided through positively and negatively valenced states of arousal (Knutson and Greer <xref ref-type="bibr" rid="CR9">2008</xref>). These findings are supported by the theoretical basis of an affective circumplex modeling of mood states, based in valence and arousal (Watson et al. <xref ref-type="bibr" rid="CR20">1999</xref>). No study to date has directly examined oxytocin effects on the hemodynamic response in social and non-social incentive processing in the brain, and how these incentive processes are influenced by change in states of affective valence and arousal.</p><sec id="Sec2"><title>The present study</title><p id="Par10">In the present study we sought to directly compare oxytocin effects in the processing of social and non-social incentives in human adults using functional magnetic resonance imaging (fMRI). For our study we used two paradigms: one being the monetary incentive delay task (MID; Cooper and Knutson <xref ref-type="bibr" rid="CR3">2008</xref>), which has been demonstrated to measure non-social incentive processing in humans, and the social incentive delay task (SID), a social incentives version of the MID task, which we designed to directly compare non-social and social incentives in fMRI. When modeling avoid loss and win conditions over neutral, we hypothesized that the VTA, SN, and NAc would have greater peak BOLD response in the oxytocin group over the placebo group at around 6&#x02013;8&#x000a0;s after social incentive anticipation (Hypothesis 1) and monetary incentive anticipation (Hypothesis 2) and that VTA, SN, and NAc would have a less pronounced BOLD undershoot at around 10&#x02013;14&#x000a0;s after social incentive anticipation (Hypothesis 3) and monetary incentive anticipation (Hypothesis 4), in line with previous studies (Hu et al. <xref ref-type="bibr" rid="CR7">2015</xref>; Mickey et al. <xref ref-type="bibr" rid="CR12">2016</xref>; Nawijn et al. <xref ref-type="bibr" rid="CR14">2016</xref>). We further expected that these increases in BOLD would be correlated with positive affect and with motivation to pursue monetary and social incentives, within their respective tasks, in line with previous findings (Mickey et al. <xref ref-type="bibr" rid="CR12">2016</xref>; Hypothesis 5).</p></sec></sec><sec id="Sec3"><title>Method</title><sec id="Sec4"><title>Participants and design</title><p id="Par11">Twenty-eight adults (8 females; 20 males) aged 18&#x02013;45 (<italic>M</italic>&#x02009;=&#x02009;29.78 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;6.05) years performed the MID and SID tasks during fMRI scans. SID scans failed for 3 participants due to scanner technical difficulties. Excessive movement artifacts were found for 1 subject in both tasks, leaving a final within-subjects sample size of 27 MID and 24 SID. Each participant performed the tasks at two separate scanning sessions, once when given an intranasal oxytocin intervention, and once when given a matched intranasal placebo intervention. The order of the tasks and intervention sessions were both counterbalanced. Exclusionary criteria included any form of MRI exclusion criteria such as metal implants or pregnancy, and any current or past psychiatric diagnosis, determined via the Mini International Neuropsychiatric Interview (Sheehan et al. <xref ref-type="bibr" rid="CR16">1998</xref>). All data was collected at the University of Utah. Informed consent was collected for all subjects. The study was reviewed and approved by the University of Utah Institutional Review Board. Protocols were registered on ClinicalTrials. gov (identifier: NCT02652195). Due to an oxytocin manufacturing change, the trial was closed earlier than expected. This study covers a sub-analysis of healthy controls to better understand the characterization of our findings in a healthy population, prior to exploring the effects in patients with alcohol use disorder.</p></sec><sec id="Sec5"><title>Oxytocin administration</title><p id="Par12">Oxytocin and matched placebo solutions were obtained from PharmaWorld (Zurich, Switzerland) and stored in a continuously temperature-monitored 4&#x000a0;&#x000b0;C refrigerator. At the scanning session, oxytocin or placebo was self-administered intranasally following verbal instructions and nasal delivery procedure was demonstrated by study staff. Participants and research staff involved in the administration remained blinded to allocation (oxytocin versus placebo). The order of allocation was determined with a computer-generated random allocation sequence without blocking (SAS software, Cary, NC, see Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). All allocations and drug assignments were concealed to both participants and study staff, except for research pharmacy personnel who prepared the drugs and did not interact with the participants. Intranasal oxytocin was administered approximately 45&#x000a0;min prior to scanning sessions.</p><p id="Par13">
<fig id="Fig1"><label>Fig. 1</label><caption><p>Randomized order of allocation for placebo versus oxytocin trials</p></caption><graphic xlink:href="213_2024_6695_Fig1_HTML" id="d33e399"/></fig>
</p></sec></sec><sec id="Sec6"><title>Behavioral measures</title><p id="Par14">We collected measures of positive and negative mood states using the Positive and Negative Affect Schedule (PANAS; Watson et al. <xref ref-type="bibr" rid="CR19">1988</xref>). We also collected measures via visual analog scales (VAS) on five emotions associated with a participant&#x02019;s perception of social and monetary incentives, for a total of ten items (social or monetary; avoid loss, win, or neutral; five emotions each). The five emotions we measured associated with their perception of social and monetary incentives were: happiness, excitement, unhappiness, fearfulness, and motivation. The social VAS asked participants to rate &#x0201c;.. how you felt about each cue during the task where you had the chance to play on someone else&#x02019;s behalf&#x0201d; and the monetary VAS asked participants to rate &#x0201c;.. how you felt about each cue during the task where you had the chance to win money for yourself.&#x0201d; The five emotions were prompted as &#x0201c;How happy?&#x0201d;, &#x0201c;How excited?&#x0201d;, &#x0201c;How unhappy?&#x0201d;, &#x0201c;How fearful?&#x0201d;, &#x0201c;How motivated?&#x0201d;. The electronic VAS scales were completed by selecting a slider with &#x0201c;Not at all&#x0201d; on the left end of the scale and &#x0201c;Extremely&#x0201d; on the right end of the scale (0-100 was the quantitative). Some participants did not complete all behavioral measures to stay within the time-sensitivity of oxytocin administration and the fMRI paradigms. A total of 20 participants completed the PANAS and 19 participants completed the VAS measures throughout sampling.</p><sec id="Sec7"><title>Paradigms</title><sec id="Sec8"><title>The monetary incentive delay task</title><p id="Par15">We used a slightly modified version of the MID task (Knutson et al. <xref ref-type="bibr" rid="CR8">2001</xref>; Cooper and Knutson <xref ref-type="bibr" rid="CR3">2008</xref>) to measure fMRI associated with non-social incentives. The task included 5 conditions: large win, small win, large avoid loss, small avoid loss, and neutral. Each trial started with a condition cue to indicate what condition the trial would be. The cue (500ms) was followed by a brief fixation mark (2&#x02013;6&#x000a0;s) and then a target star (2&#x02013;6&#x000a0;s); the subject was instructed to click on a button box before the star disappeared. If successful, they received feedback (500ms) stating that they succeeded and how much money they either gained or avoided losing. If they failed to hit the target, they received feedback that they failed along with the amount of money they either lost or failed to gain. Trial difficulty was researcher controlled to ensure roughly 66% accuracy, to sustain sufficient win versus loss power for analysis. We further tested accuracy and reaction times between placebo and oxytocin to confirm accuracy rates and measure differences in reaction times.</p></sec><sec id="Sec9"><title>The social incentive delay task</title><p id="Par16">The SID task was designed similarly to the MID task above, however it was modeled to elicit social reward rather than monetary reward. There were no small or large versions of win or avoid loss. Participants met with a partner at their lab visit before the scan. The participants were told that they would be winning money for their partner, which they would then be donating to a charity. Participants were given time to get to know and connect with the partner. Participants were told that their scan and results on the SID would be monitored by the partner. Once in the scanner, participants were shown a picture of the partner smiling with the word &#x0201c;Hit!&#x0201d; for success feedback and a picture of the partner frowning with the word &#x0201c;Miss!&#x0201d; for failure feedback, or a pixelated face for control. All remaining segments of the task were congruent to the MID (see Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref> for paradigm design). Trial accuracy was again research controlled to a rate of 66% and we tested placebo versus oxytocin effects of accuracy and reaction times.</p><p id="Par17">
<fig id="Fig2"><label>Fig. 2</label><caption><p>Experimental design of the SID and MID. Top image: SID task; Bottom image: MID task</p></caption><graphic xlink:href="213_2024_6695_Fig2_HTML" id="d33e435"/></fig>
</p></sec></sec><sec id="Sec10"><title>Power analysis</title><p id="Par18">Prior to onset of data collection, we conducted an fMRI-based power analysis using the fMRIpower software package (fmripower.org; Mumford and Nichols <xref ref-type="bibr" rid="CR13">2008</xref>). While our power analysis recommended a sample size of 45 to achieve a 90% threshold of power to detect an effect, due to the change in oxytocin manufacturing this study was cut short, and thus our sample has fallen short of 45. We believe our current sample still provides effects of interest for the literature.</p></sec><sec id="Sec11"><title>fMRI acquisition</title><p id="Par19">Whole brain functional imaging was performed on a Siemens Prisma Fit 3-T system using a T2*-sensitive simultaneous multi-slice echo planar imaging sequence (TR&#x02009;=&#x02009;0.8s, TE&#x02009;=&#x02009;30 ms, flip angle&#x02009;=&#x02009;52<sup>&#x000b0;</sup>). All data was preprocessed in fmriprep (Esteban et al. <xref ref-type="bibr" rid="CR5">2018</xref>) and included regressors for cerebral spinal fluid, white matter, and motion. Anatomy was imaged using a T1-weighted magnetization-prepared rapid gradient-echo (MPRAGE) sequence (TR&#x02009;=&#x02009;2.5s, TE&#x02009;=&#x02009;2.9 ms, flip angle&#x02009;=&#x02009;8<sup>&#x000b0;</sup>).</p></sec><sec id="Sec12"><title>fMRI analysis</title><p id="Par20">Based on our previous findings that oxytocin changes the shape of the hemodynamic response function in the mesolimbic pathway (Mickey et al. <xref ref-type="bibr" rid="CR12">2016</xref>), we extracted time-series from each region of interest using MarsBaR in SPM 12 (Brett et al. <xref ref-type="bibr" rid="CR1">2002</xref>): bilateral VTA/SN (merged as one ROI), and bilateral NAc (see Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref> for ROIs). The NAc was defined using the individual brain atlas process in SPM12 (IBASPM) and the VTA/SN was defined using the ROI used in Mickey et al. (<xref ref-type="bibr" rid="CR12">2016</xref>). Each time-series consisted of beta-weights from condition regressors of the tasks, averaged into ten 2-second time bins (e.g. time bin 1&#x02009;=&#x02009;the average beta-weight recording across 0 to 2&#x000a0;s post cue onset), starting from the onset of the condition cue to 20&#x000a0;s post onset. To compare the SID and MID tasks more easily, the small win and loss conditions of the MID were excluded in the main analysis. The remaining MID condition regressors included the following: large win anticipation, large avoid loss anticipation, and neutral anticipation. The SID condition regressors included the following: win anticipation, avoid loss anticipation, and neutral anticipation. To examine oxytocin effects across time for the entire tasks, all conditions (win, loss, neutral) were averaged together into a single time-series for placebo and a single time-series for oxytocin.</p></sec><sec id="Sec13"><title>Time-series analysis</title><p id="Par21">We used linear mixed modeling in R software (version 4.0.3) using the nlme package (version 3.1). Regressor beta weights were modeled for each paradigm separately (MID &#x00026; SID). Fixed effects were time, drug (oxytocin versus placebo), condition (win, loss, or neutral), region of interest (ROI), and all interactions; the random effect was subject. Type-II Wald chi-square tests were used for hypothesis testing. The linear effect of time was modeled from 6 to 14&#x000a0;s post onset of anticipation cue, where we saw the most variability of interest in the hemodynamic response. We also correlated differences between oxytocin and placebo at each time bin for each region of interest, with the PANAS and all VAS social and monetary measures. ANOVAs were conducted to determine oxytocin effects on task performance, PANAS, and VAS measures. Neural-behavioral correlates with Bonferroni correction for all PANAS and VAS behavioral measures (p-threshold&#x02009;=&#x02009;0.007) were reported.</p><p id="Par22">
<fig id="Fig3"><label>Fig. 3</label><caption><p>Masks used for region of interest analysis; contains the VTA/SN (red), and NAc (green)</p></caption><graphic xlink:href="213_2024_6695_Fig3_HTML" id="d33e483"/></fig>
</p></sec></sec><sec id="Sec14" sec-type="results"><title>Results</title><sec id="Sec15"><title>Behavior</title><sec id="Sec16"><title>MID task performance</title><p id="Par23">We found no effects of oxytocin on MID accuracy for win (<italic>t</italic>(49)&#x02009;=&#x02009;0.32, <italic>p</italic>&#x02009;=&#x02009;0.75; oxytocin: <italic>M</italic>&#x02009;=&#x02009;0.67 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.04; placebo: <italic>M</italic>&#x02009;=&#x02009;0.67 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.03), avoid loss (<italic>t</italic>(49)&#x02009;=&#x02009;1.01, <italic>p</italic>&#x02009;=&#x02009;0.32; oxytocin: <italic>M</italic>&#x02009;=&#x02009;0.70 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.01; placebo: <italic>M</italic>&#x02009;=&#x02009;0.69 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.02), or neutral (<italic>t</italic>(49)&#x02009;=&#x02009;0.56, <italic>p</italic>&#x02009;=&#x02009;0.57; oxytocin: <italic>M</italic>&#x02009;=&#x02009;0.63 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.19; placebo: <italic>M</italic>&#x02009;=&#x02009;0.61 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.18). We also found no effects of oxytocin on MID reaction time for win (<italic>t</italic>(49)&#x02009;=&#x02009;0.76, <italic>p</italic>&#x02009;=&#x02009;0.45; oxytocin: <italic>M</italic>&#x02009;=&#x02009;0.19 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.01; placebo: <italic>M</italic>&#x02009;=&#x02009;0.20 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.01), avoid loss (<italic>t</italic>(49)&#x02009;=&#x02009;0.70, <italic>p</italic>&#x02009;=&#x02009;0.48; oxytocin: <italic>M</italic>&#x02009;=&#x02009;0.13 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.02; placebo: <italic>M</italic>&#x02009;=&#x02009;0.13 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.02), or neutral (<italic>t</italic>(49)&#x02009;=&#x02009;0.28, <italic>p</italic>&#x02009;=&#x02009;0.78; oxytocin: <italic>M</italic>&#x02009;=&#x02009;0.20 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.01; placebo: <italic>M</italic>&#x02009;=&#x02009;0.20 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.01).</p></sec><sec id="Sec17"><title>SID task performance</title><p id="Par24">We found no effects of oxytocin on SID accuracy for win (<italic>t</italic>(49)&#x02009;=&#x02009;0.35, <italic>p</italic>&#x02009;=&#x02009;0.73; oxytocin: <italic>M</italic>&#x02009;=&#x02009;0.65 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.04; placebo: <italic>M</italic>&#x02009;=&#x02009;0.65 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.04), avoid loss (<italic>t</italic>(49)&#x02009;=&#x02009;0.21, <italic>p</italic>&#x02009;=&#x02009;0.84; oxytocin: <italic>M</italic>&#x02009;=&#x02009;0.65 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.03; placebo: <italic>M</italic>&#x02009;=&#x02009;0.66 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.06), or neutral (<italic>t</italic>(49)&#x02009;=&#x02009;0.36, <italic>p</italic>&#x02009;=&#x02009;0.72; oxytocin: <italic>M</italic>&#x02009;=&#x02009;0.67 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.19; placebo: <italic>M</italic>&#x02009;=&#x02009;0.65 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.18). We also found no effects of oxytocin on SID reaction time for win (<italic>t</italic>(49)&#x02009;=&#x02009;0.34, <italic>p</italic>&#x02009;=&#x02009;0.73; oxytocin: <italic>M</italic>&#x02009;=&#x02009;0.20 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.02; placebo: <italic>M</italic>&#x02009;=&#x02009;0.20 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.01), avoid loss (<italic>t</italic>(49)&#x02009;=&#x02009;0.08, <italic>p</italic>&#x02009;=&#x02009;0.94; oxytocin: <italic>M</italic>&#x02009;=&#x02009;0.17 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.01; placebo: <italic>M</italic>&#x02009;=&#x02009;0.17 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.01), or neutral (<italic>t</italic>(49)&#x02009;=&#x02009;0.23, <italic>p</italic>&#x02009;=&#x02009;0.82; oxytocin: <italic>M</italic>&#x02009;=&#x02009;0.21 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.02; placebo: <italic>M</italic>&#x02009;=&#x02009;0.20 <italic>SD</italic>&#x02009;&#x000b1;&#x02009;0.01).</p></sec><sec id="Sec18"><title>Mood states related to monetary incentives</title><p id="Par25">We found no effects of oxytocin related to self-perceived happiness across feedback conditions (<italic>F</italic>(1, 52)&#x02009;=&#x02009;0.07, <italic>p</italic>&#x02009;=&#x02009;0.79), excited (<italic>F</italic>(1, 53)&#x02009;=&#x02009;0.15, <italic>p</italic>&#x02009;=&#x02009;0.70), unhappiness (<italic>F</italic>(1, 53)&#x02009;=&#x02009;0.15, <italic>p</italic>&#x02009;=&#x02009;0.70), fearfulness (<italic>F</italic>(1, 53)&#x02009;=&#x02009;0.01, <italic>p</italic>&#x02009;=&#x02009;0.95), nor motivation (<italic>F</italic>(1, 53)&#x02009;=&#x02009;0.06, <italic>p</italic>&#x02009;=&#x02009;0.81) in relation to monetary incentives.</p></sec><sec id="Sec19"><title>Mood states related to social incentives</title><p id="Par26">We found no effects of oxytocin on self-reported happiness (<italic>F</italic>(1, 52)&#x02009;=&#x02009;0.35, <italic>p</italic>&#x02009;=&#x02009;0.56), excited (<italic>F</italic>(1, 52)&#x02009;=&#x02009;1.37, <italic>p</italic>&#x02009;=&#x02009;0.25), unhappiness (<italic>F</italic>(1, 52)&#x02009;=&#x02009;0.001, <italic>p</italic>&#x02009;=&#x02009;0.97), fearfulness (<italic>F</italic>(1, 52)&#x02009;=&#x02009;0.03, <italic>p</italic>&#x02009;=&#x02009;0.87), or motivation (<italic>F</italic>(1, 52)&#x02009;=&#x02009;0.06, <italic>p</italic>&#x02009;=&#x02009;0.80) in relation to social incentives.</p></sec><sec id="Sec20"><title>Oxytocin effects on affective state (PANAS)</title><p id="Par27">We found no effects of oxytocin on positive or negative affect (<italic>F</italic>(1, 53)&#x02009;=&#x02009;2.16, <italic>p</italic>&#x02009;=&#x02009;0.15).</p></sec></sec><sec id="Sec21"><title>Neural responses during the tasks</title><p id="Par28">See Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> for complete linear mixed model of the MID and Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref> for the complete linear mixed model of the SID.</p><sec id="Sec22"><title>Main effects of time</title><p id="Par29">For both the MID (<italic>&#x003c7;</italic><sup><italic>2</italic></sup>(3)&#x02009;=&#x02009;276.74, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.0001) and SID (<italic>&#x003c7;</italic><sup><italic>2</italic></sup>(3)&#x02009;=&#x02009;146.56, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.0001) we found an effect of time, with both tasks eliciting the expected peak BOLD responses at 6&#x02013;8&#x000a0;s in both ROIs (see Figs.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref> and <xref rid="Fig5" ref-type="fig">5</xref>).</p><p id="Par30">
<fig id="Fig4"><label>Fig. 4</label><caption><p>Time-series of oxytocin effects across all conditions</p></caption><graphic xlink:href="213_2024_6695_Fig4_HTML" id="d33e852"/></fig>
</p><p id="Par31">
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Linear mixed model of hemodynamic response in ROIs with oxytocin versus placebo: Monetary incentive delay task</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">&#x003c7;<sup>2</sup></th><th align="left">df</th><th align="left">
<italic>p</italic>
</th></tr><tr><th align="left" colspan="4">Factor</th></tr></thead><tbody><tr><td align="left">Time</td><td char="." align="char">276.74</td><td align="left">3</td><td char="." align="char">&#x0003c;&#x02009;0.0001*</td></tr><tr><td align="left">Oxytocin</td><td char="." align="char">1.84</td><td align="left">1</td><td char="." align="char">0.18</td></tr><tr><td align="left">Condition</td><td char="." align="char">13.79</td><td align="left">2</td><td char="." align="char">0.001*</td></tr><tr><td align="left">ROI</td><td char="." align="char">0.81</td><td align="left">1</td><td char="." align="char">0.37</td></tr><tr><td align="left">Time X Oxytocin</td><td char="." align="char">5.81</td><td align="left">3</td><td char="." align="char">0.12</td></tr><tr><td align="left">Time X Condition</td><td char="." align="char">37.14</td><td align="left">6</td><td char="." align="char">&#x0003c;&#x02009;0.0001*</td></tr><tr><td align="left">Time X ROI</td><td char="." align="char">1.72</td><td align="left">3</td><td char="." align="char">0.63</td></tr><tr><td align="left">Oxytocin X Condition</td><td char="." align="char">7.53</td><td align="left">2</td><td char="." align="char">0.02*</td></tr><tr><td align="left">Oxytocin X ROI</td><td char="." align="char">0.63</td><td align="left">1</td><td char="." align="char">0.43</td></tr><tr><td align="left">Condition X ROI</td><td char="." align="char">12.18</td><td align="left">2</td><td char="." align="char">0.002*</td></tr><tr><td align="left">Time X Oxytocin X Condition</td><td char="." align="char">1.19</td><td align="left">6</td><td char="." align="char">0.98</td></tr><tr><td align="left">Time X Oxytocin X ROI</td><td char="." align="char">0.74</td><td align="left">3</td><td char="." align="char">0.86</td></tr><tr><td align="left">Time X Condition X ROI</td><td char="." align="char">3.43</td><td align="left">6</td><td char="." align="char">0.75</td></tr><tr><td align="left">Oxytocin X Condition X ROI</td><td char="." align="char">7.24</td><td align="left">2</td><td char="." align="char">0.03*</td></tr><tr><td align="left">Time X Oxytocin X Condition X ROI</td><td char="." align="char">1.93</td><td align="left">6</td><td char="." align="char">0.93</td></tr></tbody></table></table-wrap>
</p><p id="Par32">
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Linear mixed model of hemodynamic response in ROIs with oxytocin versus placebo: social incentive delay task</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">&#x003c7;<sup>2</sup></th><th align="left">df</th><th align="left">
<italic>p</italic>
</th></tr><tr><th align="left" colspan="4">Factor</th></tr></thead><tbody><tr><td align="left">Time</td><td char="." align="char">146.56</td><td align="left">3</td><td char="." align="char">&#x0003c;&#x02009;0.0001*</td></tr><tr><td align="left">Oxytocin</td><td char="." align="char">0.49</td><td align="left">1</td><td char="." align="char">0.48</td></tr><tr><td align="left">Condition</td><td char="." align="char">43.39</td><td align="left">2</td><td char="." align="char">&#x0003c;&#x02009;0.0001*</td></tr><tr><td align="left">ROI</td><td char="." align="char">0.005</td><td align="left">1</td><td char="." align="char">0.94</td></tr><tr><td align="left">Time X Oxytocin</td><td char="." align="char">1.49</td><td align="left">3</td><td char="." align="char">0.68</td></tr><tr><td align="left">Time X Condition</td><td char="." align="char">11.17</td><td align="left">6</td><td char="." align="char">0.08</td></tr><tr><td align="left">Time X ROI</td><td char="." align="char">5.31</td><td align="left">3</td><td char="." align="char">0.15</td></tr><tr><td align="left">Oxytocin X Condition</td><td char="." align="char">6.64</td><td align="left">2</td><td char="." align="char">0.04*</td></tr><tr><td align="left">Oxytocin X ROI</td><td char="." align="char">0.33</td><td align="left">1</td><td char="." align="char">0.56</td></tr><tr><td align="left">Condition X ROI</td><td char="." align="char">6.08</td><td align="left">2</td><td char="." align="char">0.048*</td></tr><tr><td align="left">Time X Oxytocin X Condition</td><td char="." align="char">6.80</td><td align="left">6</td><td char="." align="char">0.34</td></tr><tr><td align="left">Time X Oxytocin X ROI</td><td char="." align="char">1.57</td><td align="left">3</td><td char="." align="char">0.67</td></tr><tr><td align="left">Time X Condition X ROI</td><td char="." align="char">4.83</td><td align="left">6</td><td char="." align="char">0.57</td></tr><tr><td align="left">Oxytocin X Condition X ROI</td><td char="." align="char">2.92</td><td align="left">2</td><td char="." align="char">0.23</td></tr><tr><td align="left">Time X Oxytocin X Condition X ROI</td><td char="." align="char">2.67</td><td align="left">6</td><td char="." align="char">0.85</td></tr></tbody></table></table-wrap>
</p></sec><sec id="Sec23"><title>Responses vary across condition and brain region</title><p id="Par33">For the MID we found a two-way interaction effect of time X condition, <italic>&#x003c7;</italic><sup><italic>2</italic></sup>(6)&#x02009;=&#x02009;37.14, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.0001 and a main effect of condition, <italic>&#x003c7;</italic><sup><italic>2</italic></sup>(2)&#x02009;=&#x02009;13.79, <italic>p</italic>&#x02009;=&#x02009;0.001. For the SID we found a main effect of condition, <italic>&#x003c7;</italic><sup><italic>2</italic></sup>(2)&#x02009;=&#x02009;43.39, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.0001, with both tasks in general eliciting greater responses during avoid loss and win trials, over neutral trials (see Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). We found a condition X ROI interaction for both the MID (<italic>X</italic><sup><italic>2</italic></sup>(2)&#x02009;=&#x02009;12.18, <italic>p</italic>&#x02009;=&#x02009;0.002) and the SID (<italic>&#x003c7;</italic><sup><italic>2</italic></sup>(2)&#x02009;=&#x02009;6.08, <italic>p</italic>&#x02009;=&#x02009;0.048). Figure&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref> illustrates this variation between ROIs and across condition for each task.</p><p id="Par34">
<fig id="Fig5"><label>Fig. 5</label><caption><p>Response versus condition, Collapsed across oxytocin and placebo</p></caption><graphic xlink:href="213_2024_6695_Fig5_HTML" id="d33e1255"/></fig>
</p></sec></sec><sec id="Sec24"><title>Effects of oxytocin on neural responses</title><sec id="Sec25"><title>Oxytocin does not affect response amplitude or shape when collapsing across condition</title><p id="Par35">We saw no main effects of oxytocin on hemodynamic response in either the MID, <italic>X</italic><sup><italic>2</italic></sup>(1)&#x02009;=&#x02009;1.84, <italic>p</italic>&#x02009;=&#x02009;0.18, or the SID, <italic>X</italic><sup><italic>2</italic></sup>(1)&#x02009;=&#x02009;0.49, <italic>p</italic>&#x02009;=&#x02009;0.48. We also saw no oxytocin X time interactions in either the MID, <italic>X</italic><sup><italic>2</italic></sup>(3)&#x02009;=&#x02009;5.81, <italic>p</italic>&#x02009;=&#x02009;0.12, or the SID, <italic>X</italic><sup><italic>2</italic></sup>(3)&#x02009;=&#x02009;1.49, <italic>p</italic>&#x02009;=&#x02009;0.68, indicating the amplitude and shape of BOLD response remains constant across oxytocin and tasks (see Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>).</p></sec><sec id="Sec26"><title>Oxytocin modulates condition-specific responses</title><p id="Par36">For both the MID (<italic>&#x003c7;</italic><sup><italic>2</italic></sup>(2)&#x02009;=&#x02009;7.53, <italic>p</italic>&#x02009;=&#x02009;0.02) and the SID (<italic>&#x003c7;</italic><sup><italic>2</italic></sup>(2)&#x02009;=&#x02009;6.64, <italic>p</italic>&#x02009;=&#x02009;0.04), we saw an oxytocin X condition interaction, showing that oxytocin modulates condition-specific responses during both monetary and social incentive processing (see Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>). For the MID we also found a three-way interaction effect of oxytocin X condition X ROI, <italic>&#x003c7;</italic><sup><italic>2</italic></sup>(2)&#x02009;=&#x02009;7.24, <italic>p</italic>&#x02009;=&#x02009;0.03, suggesting an ROI-specific effect of oxytocin only during the MID (see Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>).</p><p id="Par37">MID contrasts with the neutral condition subtracted (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>) indicated that oxytocin tended to reduce BOLD signal in VTA/SN and increase BOLD signal in NAc. The largest effect of oxytocin was an enhancement of the BOLD undershoot at 12&#x000a0;s in the VTA/SN during the monetary loss condition. With the SID task, contrasts with the neutral condition subtracted (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>) showed that oxytocin tended to flatten the BOLD response across conditions in both VTA/SN and NAc. The most prominent effect was an oxytocin-induced suppression of the BOLD signal peak at 8&#x000a0;s in the NAc during the social win condition.</p><p id="Par38">
<fig id="Fig6"><label>Fig. 6</label><caption><p>Time-series of oxytocin effects by condition after subtraction of neutral control</p></caption><graphic xlink:href="213_2024_6695_Fig6_HTML" id="d33e1357"/></fig>
</p></sec></sec><sec id="Sec27"><title>Neural-behavioral correlations</title><p id="Par39">For the VTA/SN during the MID, increases in feelings of happiness for monetary reward were correlated with decreases in BOLD response from oxytocin (oxytocin &#x02013; placebo) at 10&#x02013;12&#x000a0;s post-onset, <italic>r</italic>(17) = -0.61, <italic>pcorr</italic>&#x02009;&#x0003c;&#x02009;0.007. For the NAc during the SID, increases in feelings of motivation for social reward were correlated with increases in BOLD response from oxytocin (oxytocin &#x02013; placebo) at 8&#x02013;10&#x000a0;s post-onset, <italic>r</italic>(17)&#x02009;=&#x02009;0.64, <italic>p</italic>corr&#x02009;&#x0003c;&#x02009;0.007.</p><p id="Par40">All other correlations of BOLD response and task-related mood states or PANAS scales across our 6&#x02013;14 post-onset time window of interest were not statistically significant (<italic>pcorr</italic>&#x02009;&#x0003e;&#x02009;0.007). For significant uncorrected neural-behavioral correlates, see Supplemental Table 1.</p></sec></sec><sec id="Sec28" sec-type="discussion"><title>Discussion</title><p id="Par41">Contrary to Hypothesis 1 we found no significant increase in peak BOLD response (6&#x02013;8&#x000a0;s) in the oxytocin group during SID anticipation, across both ROIs and both conditions over neutral. In further contradiction to Hypothesis 1, we saw a decrease in BOLD peak in the NAc during win anticipation specifically. Contrary to Hypothesis 2 we found no significant increase in peak BOLD response (6&#x02013;8&#x000a0;s) in the oxytocin group during MID anticipation, across both ROIs and both conditions. In further contradiction to Hypothesis 2, we observed a decrease in peak BOLD response in the oxytocin group during MID anticipation, specifically in the VTA/SN during win anticipation over neutral of the MID. Congruent with our Hypothesis 3, we found a less pronounced BOLD undershoot at 14&#x000a0;s in both the VTA/SN and the NAc, during SID avoid loss over neutral trials specifically. In contradiction to Hypothesis 3, we found a more pronounced BOLD undershoot at 10&#x000a0;s during SID win anticipation over neutral. Congruent with our Hypothesis 4, we found a less pronounced BOLD undershoot at 12&#x000a0;s during win anticipation of the MID, however in contradiction to our Hypothesis 4, we found a more pronounced BOLD undershoot from 10 to 12&#x000a0;s of the MID. Contradictory with our Hypothesis 5, feelings of happiness for monetary reward were associated with less BOLD response at 10&#x02013;12&#x000a0;s post MID anticipation in the VTA/SN, however congruent with our Hypothesis 5, feelings of motivation for social reward were associated with increases in BOLD response at 8&#x02013;10&#x000a0;s post SID anticipation in the NAc. Several uncorrected neural correlate effects were observed but these may be due to smaller effect sizes or false positive findings. Further, our lack of whole-brain analysis is related to the fact that the factor of time is collapsed and we wanted to underscore the importance of measuring oxytocin effects in BOLD via time-series analyses.</p><p id="Par42">Our SID BOLD findings for oxytocin suggests that oxytocin may function in a similar way to social reward as it was shown to function for food reward in Spetter et al. (<xref ref-type="bibr" rid="CR17">2018</xref>). The less pronounced undershoot of the BOLD response in VTA/SN and NAc, may enhance the salience of social rewards, while the reduction of the peak BOLD response in the NAc may simultaneously be regulating a selective filter about what social rewards to actively engage in. We saw an opposite pattern in the MID where oxytocin may be decreasing reward salience to monetary incentives in the VTA/SN while at the same time increasing the NAc motivation to interact with monetary rewards. Those motivated for social reward may experience less of a reward filter from oxytocin, while those who associate happiness with monetary reward may have a reduced reward salience to monetary incentives.</p><p id="Par43">Like Spetter et al. (<xref ref-type="bibr" rid="CR17">2018</xref>), these findings suggest a more multifaceted influence of oxytocin on reward incentive processing. Specifically, that oxytocin influences both the salience of reward and the ability to engage in cognitive control in relation to reward. These findings would be further congruent with other previous studies where Hu et al. (<xref ref-type="bibr" rid="CR7">2015</xref>) demonstrated an increase in sensitivity to social feedback from oxytocin, Nawijn et al. (<xref ref-type="bibr" rid="CR14">2016</xref>) showed oxytocin could increase reward motivation for patients with PTSD, and that an increase in cognitive control may be linked to more decision-making accuracy, as shown in Zhou et al. (<xref ref-type="bibr" rid="CR21">2024</xref>). The contradictive findings in Mayer et al. (<xref ref-type="bibr" rid="CR11">2021</xref>) may be due to the emphasis of looking at oxytocin via affective circuits rather than cognitive control circuitry.</p><p id="Par44">Together these findings and literature may suggest that oxytocin isn&#x02019;t solely important for improving the salience to reward processing but that it is more pertinent to the selectivity and cognitive control associated with reward engagement. In essence, that oxytocin may improve common cognitive processes such as delay discounting, which allow an individual to pursue an important reward over a long period of time without receiving any benefits from it until the necessary tasks associated with the long-term pursuit are completed. This would be associated with the reduction in the NAc activity that allows a person to be more effective at restraining themselves from engaging in short-term rewards that may disrupt their ability to pursue a long-term reward, while oxytocin also seems to stimulate the salience to that long-term reward over said continuous pursuit. A disruption in the oxytocin mechanisms might explain why in instances of substance abuse, patients with substance abuse disorders often still desire to pursue social and non-social rewards, yet they are unable to sustain the cognitive control necessary to not disrupt the natural process of attaining long-term rewards associated with such pursuits.</p><p id="Par45">Limitations of our study included that our sample was heavily sex biased towards males but the within-subject power elicited by both fMRI tasks may have compensated for this a bit. Our decision to also exclude small win and avoid loss trials from the MID may have reduced the power of our MID data but with previous findings showing a difference in effect size between small and large MID rewards (Mickey et al. <xref ref-type="bibr" rid="CR12">2016</xref>), we felt that this may introduce too much complexity into our models. This study was also further limited by the experimental environment itself not fully simulating real-world reward and social encounters in a more natural setting. Our study also fell short of our target sampling of 45, due to the manufacturing change in our oxytocin supplier. Future studies may wish to look at oxytocin effects between sex, as well as between healthy controls and psychiatric populations known to having reward incentive processing deficits, such as in substance and alcohol abuse disorders, in a way that can better measure whether oxytocin is influencing their deficits in delay-discounting and/or cognitive control specifically.</p></sec><sec id="Sec444" sec-type="supplementary-material"><title>Electronic supplementary material</title><p>Below is the link to the electronic supplementary material.</p><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="213_2024_6695_MOESM1_ESM.docx"><caption><p>Supplementary Material 1</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Brian J. Mickey and Tiffany M. Love contributed equally co-senior authorship.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author contributions</title><p>MDT conducted analysis and generated initial manuscript draft, LCE supported acquisition and preprocessing pipelines of data collection. MMJ &#x00026; AB assisted in data collection. TML, BJM, &#x00026; VK provided inception of study and study design. BJM &#x00026; TML provided oversight and guidance to analysis approach of the data. LCE, MMJ, VK, TML, &#x00026; BJM provided feedback and manuscript edits.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>The research was supported by NIH/NIAAA K01 award number 1K01AA024167-01 and the National Center for Advancing Translational Sciences of the National Institutes of Health under award Number UL- 1TR001067 for period 5/1/13&#x02013;3/30/18 and UL1TR002538 for period 4/1/18&#x02009;&#x02212;&#x02009;2/28/23. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Much appreciation and gratitude to all the research technicians, assistants, and students who assisted in data collection and implementation of this study, without whom this work would have not been possible.</p><p> Open Access funding enabled and organized by CAUL and its Member Institutions</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par46">The authors have no conflicts of interest to declare.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><mixed-citation publication-type="other">Brett M, Anton J-L, Valabregue R, Poline J-P (2002) Region of interest analysis using an SPM toolbox [abstract] Presented at the 8th International Conference on Functional Mapping of the Human Brain, June 2&#x02013;6, 2002, Sendai, Japan. Available on CD-ROM in NeuroImage, Vol 16, No 2</mixed-citation></ref><ref id="CR2"><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Bromberg-Martin</surname><given-names>ES</given-names></name><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Hikosaka</surname><given-names>O</given-names></name></person-group><article-title>Dopamine in motivational control: rewarding, aversive, and alerting</article-title><source>Neuron</source><year>2010</year><volume>68</volume><issue>5</issue><fpage>815</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2010.11.022</pub-id><pub-id pub-id-type="pmid">21144997</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Bromberg-Martin ES, Matsumoto M, Hikosaka O (2010) Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 68(5):815&#x02013;834. 10.1016/j.neuron.2010.11.022<pub-id pub-id-type="pmid">21144997</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>JC</given-names></name><name><surname>Knutson</surname><given-names>B</given-names></name></person-group><article-title>Valence and salience contribute to nucleus accumbens activation</article-title><source>NeuroImage</source><year>2008</year><volume>39</volume><issue>1</issue><fpage>538</fpage><lpage>547</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2007.08.009</pub-id><pub-id pub-id-type="pmid">17904386</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Cooper JC, Knutson B (2008) Valence and salience contribute to nucleus accumbens activation. NeuroImage 39(1):538&#x02013;547. 10.1016/j.neuroimage.2007.08.009<pub-id pub-id-type="pmid">17904386</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Der-Avakian</surname><given-names>A</given-names></name><name><surname>Barnes</surname><given-names>SA</given-names></name><name><surname>Markou</surname><given-names>A</given-names></name><name><surname>Pizzagalli</surname><given-names>DA</given-names></name></person-group><article-title>Translational Assessment of reward and motivational deficits in Psychiatric disorders</article-title><source>Curr Top Behav Neurosci</source><year>2016</year><volume>28</volume><fpage>231</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1007/7854_2015_5004</pub-id><pub-id pub-id-type="pmid">26873017</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Der-Avakian A, Barnes SA, Markou A, Pizzagalli DA (2016) Translational Assessment of reward and motivational deficits in Psychiatric disorders. Curr Top Behav Neurosci 28:231&#x02013;262. 10.1007/7854_2015_5004<pub-id pub-id-type="pmid">26873017</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Esteban</surname><given-names>O</given-names></name><name><surname>Markiewicz</surname><given-names>CJ</given-names></name><name><surname>Blair</surname><given-names>RW</given-names></name><name><surname>Moodie</surname><given-names>CA</given-names></name><name><surname>Isik</surname><given-names>AI</given-names></name><name><surname>Erramuzpe</surname><given-names>A</given-names></name><name><surname>Kent</surname><given-names>JD</given-names></name><name><surname>Goncalves</surname><given-names>M</given-names></name><name><surname>DuPre</surname><given-names>E</given-names></name><name><surname>Snyder</surname><given-names>M</given-names></name><name><surname>Oya</surname><given-names>H</given-names></name><name><surname>Ghosh</surname><given-names>SS</given-names></name><name><surname>Wright</surname><given-names>J</given-names></name><name><surname>Durnez</surname><given-names>J</given-names></name><name><surname>Poldrack</surname><given-names>RA</given-names></name><name><surname>Gorgolewski</surname><given-names>KJ</given-names></name></person-group><article-title>fMRIPrep: a robust preprocessing pipeline for functional MRI</article-title><source>Nat Meth</source><year>2018</year><pub-id pub-id-type="doi">10.1038/s41592-018-0235-4</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Esteban O, Markiewicz CJ, Blair RW, Moodie CA, Isik AI, Erramuzpe A, Kent JD, Goncalves M, DuPre E, Snyder M, Oya H, Ghosh SS, Wright J, Durnez J, Poldrack RA, Gorgolewski KJ (2018) fMRIPrep: a robust preprocessing pipeline for functional MRI. Nat Meth. 10.1038/s41592-018-0235-4</mixed-citation></citation-alternatives></ref><ref id="CR6"><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>R</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Camilleri</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>P</given-names></name><name><surname>Wei</surname><given-names>P</given-names></name><name><surname>Eickhoff</surname><given-names>SB</given-names></name><name><surname>Feng</surname><given-names>C</given-names></name></person-group><article-title>Love is analogous to money in human brain: coordinate-based and functional connectivity meta-analyses of social and monetary reward anticipation</article-title><source>Neurosci Biobehavrioal Rev</source><year>2019</year><volume>100</volume><fpage>108</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2019.02.017</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Gu R, Huang W, Camilleri J, Xu P, Wei P, Eickhoff SB, Feng C (2019) Love is analogous to money in human brain: coordinate-based and functional connectivity meta-analyses of social and monetary reward anticipation. Neurosci Biobehavrioal Rev 100:108&#x02013;128. 10.1016/j.neubiorev.2019.02.017</mixed-citation></citation-alternatives></ref><ref id="CR7"><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Qi</surname><given-names>S</given-names></name><name><surname>Becker</surname><given-names>B</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>S</given-names></name><name><surname>Gong</surname><given-names>Q</given-names></name><name><surname>Hurlemann</surname><given-names>R</given-names></name><name><surname>Kendrick</surname><given-names>KM</given-names></name></person-group><article-title>Oxytocin selectively facilitates learning with social feedback and increases activity and functional connectivity in emotional memory and reward processing regions</article-title><source>Hum Brain Mapp</source><year>2015</year><volume>36</volume><fpage>2132</fpage><lpage>2146</lpage><pub-id pub-id-type="doi">10.1002/hbm.22760</pub-id><pub-id pub-id-type="pmid">25664702</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Hu J, Qi S, Becker B, Luo L, Gao S, Gong Q, Hurlemann R, Kendrick KM (2015) Oxytocin selectively facilitates learning with social feedback and increases activity and functional connectivity in emotional memory and reward processing regions. Hum Brain Mapp 36:2132&#x02013;2146. 10.1002/hbm.22760<pub-id pub-id-type="pmid">25664702</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Knutson</surname><given-names>B</given-names></name><name><surname>Greer</surname><given-names>SM</given-names></name></person-group><article-title>Anticipatory affect: neural correlates and consequences for choice</article-title><source>Phil Trans R Soc</source><year>2008</year><volume>363</volume><fpage>3771</fpage><lpage>3786</lpage><pub-id pub-id-type="doi">10.1098/rstb.2008.0155</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Knutson B, Greer SM (2008) Anticipatory affect: neural correlates and consequences for choice. Phil Trans R Soc 363:3771&#x02013;3786. 10.1098/rstb.2008.0155</mixed-citation></citation-alternatives></ref><ref id="CR8"><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Knutson</surname><given-names>B</given-names></name><name><surname>Adams</surname><given-names>CM</given-names></name><name><surname>Fong</surname><given-names>GW</given-names></name><name><surname>Hommer</surname><given-names>D</given-names></name></person-group><article-title>Anticipation of increasing monetary reward selectively recruits nucleus accumbens</article-title><source>J Neurosci</source><year>2001</year><volume>21</volume><fpage>RC159</fpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-16-j0002.2001</pub-id><pub-id pub-id-type="pmid">11459880</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Knutson B, Adams CM, Fong GW, Hommer D (2001) Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J Neurosci 21:RC159<pub-id pub-id-type="pmid">11459880</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>TM</given-names></name></person-group><article-title>Oxytocin, motivation and the role of dopamine</article-title><source>Pharmacol Biochem Behav</source><year>2014</year><volume>0</volume><fpage>49</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/j.pbb.2013.06.011</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Love TM (2014) Oxytocin, motivation and the role of dopamine. Pharmacol Biochem Behav 0:49&#x02013;60. 10.1016/j.pbb.2013.06.011</mixed-citation></citation-alternatives></ref><ref id="CR11"><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>AV</given-names></name><name><surname>Preckel</surname><given-names>K</given-names></name><name><surname>Ihle</surname><given-names>K</given-names></name><name><surname>Piecha</surname><given-names>FA</given-names></name><name><surname>Junghanns</surname><given-names>K</given-names></name><name><surname>Reiche</surname><given-names>S</given-names></name><name><surname>Rademacher</surname><given-names>L</given-names></name><name><surname>Muller-Pinzler</surname><given-names>L</given-names></name><name><surname>Stolz</surname><given-names>DS</given-names></name><name><surname>Kamp-Becker</surname><given-names>I</given-names></name><name><surname>Stroth</surname><given-names>S</given-names></name><name><surname>Roepke</surname><given-names>S</given-names></name><name><surname>Kupper</surname><given-names>C</given-names></name><name><surname>Engert</surname><given-names>V</given-names></name><name><surname>Singer</surname><given-names>T</given-names></name><name><surname>Kanske</surname><given-names>P</given-names></name><name><surname>Paulus</surname><given-names>FM</given-names></name><name><surname>Krach</surname><given-names>S</given-names></name></person-group><article-title>Assessment of reward-related brain function after a single dose of oxytocin in autism: a randomized controlled trial</article-title><source>Biol Psychiatry Global Open Sci</source><year>2021</year><volume>2</volume><fpage>136</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/j.bpsgos.2021.10.004</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Mayer AV, Preckel K, Ihle K, Piecha FA, Junghanns K, Reiche S, Rademacher L, Muller-Pinzler L, Stolz DS, Kamp-Becker I, Stroth S, Roepke S, Kupper C, Engert V, Singer T, Kanske P, Paulus FM, Krach S (2021) Assessment of reward-related brain function after a single dose of oxytocin in autism: a randomized controlled trial. Biol Psychiatry Global Open Sci 2:136&#x02013;146. 10.1016/j.bpsgos.2021.10.004</mixed-citation></citation-alternatives></ref><ref id="CR12"><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Mickey</surname><given-names>BJ</given-names></name><name><surname>Heffernan</surname><given-names>J</given-names></name><name><surname>Heisel</surname><given-names>C</given-names></name><name><surname>Pecina</surname><given-names>M</given-names></name><name><surname>Hsu</surname><given-names>DT</given-names></name><name><surname>Zubieta</surname><given-names>J-K</given-names></name><name><surname>Love</surname><given-names>TM</given-names></name></person-group><article-title>Oxytocin modulates hemodynamic responses to monetary incentives in humans</article-title><source>Psychopharmacology</source><year>2016</year><volume>233</volume><issue>23&#x02013;24</issue><fpage>3905</fpage><lpage>3919</lpage><pub-id pub-id-type="doi">10.1007/s00213-016-4423-6</pub-id><pub-id pub-id-type="pmid">27614896</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Mickey BJ, Heffernan J, Heisel C, Pecina M, Hsu DT, Zubieta J-K, Love TM (2016) Oxytocin modulates hemodynamic responses to monetary incentives in humans. Psychopharmacology 233(23&#x02013;24):3905&#x02013;3919. 10.1007/s00213-016-4423-6<pub-id pub-id-type="pmid">27614896</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Mumford</surname><given-names>JA</given-names></name><name><surname>Nichols</surname><given-names>TE</given-names></name></person-group><article-title>Power calculation for group fMRI studies accounting for arbitrary design and temporal autocorrelation</article-title><source>NeuroImage</source><year>2008</year><volume>39</volume><issue>1</issue><fpage>261</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2007.07.061</pub-id><pub-id pub-id-type="pmid">17919925</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Mumford JA, Nichols TE (2008) Power calculation for group fMRI studies accounting for arbitrary design and temporal autocorrelation. NeuroImage 39(1):261&#x02013;268. 10.1016/j.neuroimage.2007.07.061<pub-id pub-id-type="pmid">17919925</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Nawijn</surname><given-names>L</given-names></name><name><surname>Zuiden</surname><given-names>M</given-names></name><name><surname>Koch</surname><given-names>SBJ</given-names></name><name><surname>Frijling</surname><given-names>JL</given-names></name><name><surname>Veltman</surname><given-names>DJ</given-names></name><name><surname>Olff</surname><given-names>M</given-names></name></person-group><article-title>Intranasal oxytocin enhances neural processing of monetary reward and loss in post-traumatic stress disorder and traumatized controls</article-title><source>Psychoneuroendocrinology</source><year>2016</year><volume>66</volume><fpage>228</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1016/j.psyneuen.2016.01.020</pub-id><pub-id pub-id-type="pmid">26851698</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Nawijn L, Zuiden M, Koch SBJ, Frijling JL, Veltman DJ, Olff M (2016) Intranasal oxytocin enhances neural processing of monetary reward and loss in post-traumatic stress disorder and traumatized controls. Psychoneuroendocrinology 66:228&#x02013;237. 10.1016/j.psyneuen.2016.01.020<pub-id pub-id-type="pmid">26851698</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Poulton</surname><given-names>A</given-names></name><name><surname>Hester</surname><given-names>R</given-names></name></person-group><article-title>Transition to substance use disorders: impulsivity for reward and learning from reward</article-title><source>Soc Cognit Affect Neurosci</source><year>2020</year><volume>15</volume><issue>10</issue><fpage>1182</fpage><lpage>1191</lpage><pub-id pub-id-type="doi">10.1093/scan/nsz077</pub-id><pub-id pub-id-type="pmid">31848627</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Poulton A, Hester R (2020) Transition to substance use disorders: impulsivity for reward and learning from reward. Soc Cognit Affect Neurosci 15(10):1182&#x02013;1191. 10.1093/scan/nsz077<pub-id pub-id-type="pmid">31848627</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Sheehan</surname><given-names>DV</given-names></name><name><surname>Lecrubier</surname><given-names>Y</given-names></name><name><surname>Harnett-Sheehan</surname><given-names>K</given-names></name><name><surname>Amorim</surname><given-names>P</given-names></name><name><surname>Janavs</surname><given-names>J</given-names></name><name><surname>Weiller</surname><given-names>E</given-names></name><name><surname>Hergueta</surname><given-names>T</given-names></name><name><surname>Baker</surname><given-names>R</given-names></name><name><surname>Dunbar</surname><given-names>G</given-names></name></person-group><article-title>The mini international neuropsychiatric interview (M.I.N.I.): the Development and validation of a structured diagnostic psychiatric interview</article-title><source>J Clin Psychiatry</source><year>1998</year><volume>59</volume><issue>suppl 20</issue><fpage>22</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">9881538</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Sheehan DV, Lecrubier Y, Harnett-Sheehan K, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar G (1998) The mini international neuropsychiatric interview (M.I.N.I.): the Development and validation of a structured diagnostic psychiatric interview. J Clin Psychiatry 59(suppl 20):22&#x02013;33<pub-id pub-id-type="pmid">9881538</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><mixed-citation publication-type="other">Spetter MS, Feld GB, Thienel M, Preissl H, Hege MA, Hallschmid M (2018) Oxytocin curbs calorie intake via food-specific increases in the activity of brain areas that process reward and establish cognitive control. Sci Rep 8. 10.1038/s41598-018-20963-4</mixed-citation></ref><ref id="CR18"><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Verharen</surname><given-names>J</given-names></name><name><surname>Adan</surname><given-names>R</given-names></name><name><surname>Vanderschuren</surname><given-names>L</given-names></name></person-group><article-title>How reward and aversion shape motivation and decision making: a computational account. The neuroscientist: a review journal bringing neurobiology</article-title><source>Neurol Psychiatry</source><year>2020</year><volume>26</volume><issue>1</issue><fpage>87</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1177/1073858419834517</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Verharen J, Adan R, Vanderschuren L (2020) How reward and aversion shape motivation and decision making: a computational account. The neuroscientist: a review journal bringing neurobiology. Neurol Psychiatry 26(1):87&#x02013;99. 10.1177/1073858419834517</mixed-citation></citation-alternatives></ref><ref id="CR19"><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>D</given-names></name><name><surname>Clark</surname><given-names>LA</given-names></name><name><surname>Tellegen</surname><given-names>A</given-names></name></person-group><article-title>Development and validation of brief measures of positive and negative affect: the PANAS scales</article-title><source>J Personal Soc Psychol</source><year>1988</year><volume>54</volume><issue>6</issue><fpage>1063</fpage><lpage>1070</lpage><pub-id pub-id-type="doi">10.1037/0022-3514.54.6.1063</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Watson D, Clark LA, Tellegen A (1988) Development and validation of brief measures of positive and negative affect: the PANAS scales. J Personal Soc Psychol 54(6):1063&#x02013;1070</mixed-citation></citation-alternatives></ref><ref id="CR20"><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>D</given-names></name><name><surname>Wiese</surname><given-names>D</given-names></name><name><surname>Vaidya</surname><given-names>J</given-names></name><name><surname>Tellegen</surname><given-names>A</given-names></name></person-group><article-title>The two general activation systems of affect: structural findings, evolutionary considerations, and psychobiological evidence</article-title><source>J Pers Soc Psychol</source><year>1999</year><volume>76</volume><fpage>820</fpage><lpage>838</lpage><pub-id pub-id-type="doi">10.1037/0022-3514.76.5.820</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Watson D, Wiese D, Vaidya J, Tellegen A (1999) The two general activation systems of affect: structural findings, evolutionary considerations, and psychobiological evidence. J Pers Soc Psychol 76:820&#x02013;838. 10.1037/0022-3514.76.5.820</mixed-citation></citation-alternatives></ref><ref id="CR21"><mixed-citation publication-type="other">Zhou M, Zhu S, Xu T, Wang J, Zhuang Q, Zhang Y, Becker B, Kendrick KM, Yao S (2024) Neural and behavioral evidence for oxytocin&#x02019;s facilitatory effects on learning in volatile and stable environments. Commun Biology 7(109). 10.1037/s42003-024-05792-B</mixed-citation></ref></ref-list></back></article>